Home > > > Report Detail

Global Genetic Engineering Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 05-Aug-2022
No. of pages: 97

The Genetic Engineering Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genetic Engineering Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medicine accounting for % of the Genetic Engineering Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibody segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Genetic Engineering Drug include Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, and Beijing SL Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Genetic Engineering Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Monoclonal Antibody

- Recombinant Human Erythropoietin

- Recombinant Human Interferon

- Recombinant Human Growth Hormone

- Recombinant Human Insulin

Market segment by Application can be divided into

- Medicine

- Research

- Industrial

- Agriculture

- Other

The key market players for global Genetic Engineering Drug market are listed below:

- Shanghai Lansheng Guojian Pharmaceutical

- Biotech Pharmaceutical

- Anhui Anke Biotechnology

- GeneScience Pharmaceuticals

- Beijing SL Pharmaceutical

- Jiangsu Sihuan Bioengineering

- Shenzhen Neptunus Interlong Bio-Technique

- 3SBio

- Tonghua Dongbao Pharmaceutical

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Genetic Engineering Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Genetic Engineering Drug, with price, sales, revenue and global market share of Genetic Engineering Drug from 2019 to 2022.

Chapter 3, the Genetic Engineering Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Genetic Engineering Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Engineering Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Engineering Drug.

Chapter 13, 14, and 15, to describe Genetic Engineering Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Genetic Engineering Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Genetic Engineering Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genetic Engineering Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Market Analysis by Application
1.3.1 Overview: Global Genetic Engineering Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Global Genetic Engineering Drug Market Size & Forecast
1.4.1 Global Genetic Engineering Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Genetic Engineering Drug Sales in Volume (2017-2028)
1.4.3 Global Genetic Engineering Drug Price (2017-2028)
1.5 Global Genetic Engineering Drug Production Capacity Analysis
1.5.1 Global Genetic Engineering Drug Total Production Capacity (2017-2028)
1.5.2 Global Genetic Engineering Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Engineering Drug Market Drivers
1.6.2 Genetic Engineering Drug Market Restraints
1.6.3 Genetic Engineering Drug Trends Analysis
2 Manufacturers Profiles
2.1 Shanghai Lansheng Guojian Pharmaceutical
2.1.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.1.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
2.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biotech Pharmaceutical
2.2.1 Biotech Pharmaceutical Details
2.2.2 Biotech Pharmaceutical Major Business
2.2.3 Biotech Pharmaceutical Genetic Engineering Drug Product and Services
2.2.4 Biotech Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Anhui Anke Biotechnology
2.3.1 Anhui Anke Biotechnology Details
2.3.2 Anhui Anke Biotechnology Major Business
2.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
2.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GeneScience Pharmaceuticals
2.4.1 GeneScience Pharmaceuticals Details
2.4.2 GeneScience Pharmaceuticals Major Business
2.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
2.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
2.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu Sihuan Bioengineering
2.6.1 Jiangsu Sihuan Bioengineering Details
2.6.2 Jiangsu Sihuan Bioengineering Major Business
2.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
2.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shenzhen Neptunus Interlong Bio-Technique
2.7.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.7.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
2.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Genetic Engineering Drug Product and Services
2.8.4 3SBio Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Tonghua Dongbao Pharmaceutical
2.9.1 Tonghua Dongbao Pharmaceutical Details
2.9.2 Tonghua Dongbao Pharmaceutical Major Business
2.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
2.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Genetic Engineering Drug Breakdown Data by Manufacturer
3.1 Global Genetic Engineering Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Genetic Engineering Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Genetic Engineering Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Genetic Engineering Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Genetic Engineering Drug Manufacturer Market Share in 2021
3.5 Global Genetic Engineering Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Genetic Engineering Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Genetic Engineering Drug Market Size by Region
4.1.1 Global Genetic Engineering Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Genetic Engineering Drug Revenue by Region (2017-2028)
4.2 North America Genetic Engineering Drug Revenue (2017-2028)
4.3 Europe Genetic Engineering Drug Revenue (2017-2028)
4.4 Asia-Pacific Genetic Engineering Drug Revenue (2017-2028)
4.5 South America Genetic Engineering Drug Revenue (2017-2028)
4.6 Middle East and Africa Genetic Engineering Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Genetic Engineering Drug Sales in Volume by Type (2017-2028)
5.2 Global Genetic Engineering Drug Revenue by Type (2017-2028)
5.3 Global Genetic Engineering Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Genetic Engineering Drug Sales in Volume by Application (2017-2028)
6.2 Global Genetic Engineering Drug Revenue by Application (2017-2028)
6.3 Global Genetic Engineering Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Genetic Engineering Drug Sales by Type (2017-2028)
7.2 North America Genetic Engineering Drug Sales by Application (2017-2028)
7.3 North America Genetic Engineering Drug Market Size by Country
7.3.1 North America Genetic Engineering Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Genetic Engineering Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Genetic Engineering Drug Sales by Type (2017-2028)
8.2 Europe Genetic Engineering Drug Sales by Application (2017-2028)
8.3 Europe Genetic Engineering Drug Market Size by Country
8.3.1 Europe Genetic Engineering Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Genetic Engineering Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Genetic Engineering Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Genetic Engineering Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Genetic Engineering Drug Market Size by Region
9.3.1 Asia-Pacific Genetic Engineering Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Genetic Engineering Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Genetic Engineering Drug Sales by Type (2017-2028)
10.2 South America Genetic Engineering Drug Sales by Application (2017-2028)
10.3 South America Genetic Engineering Drug Market Size by Country
10.3.1 South America Genetic Engineering Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Genetic Engineering Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Genetic Engineering Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Genetic Engineering Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Genetic Engineering Drug Market Size by Country
11.3.1 Middle East & Africa Genetic Engineering Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Genetic Engineering Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Genetic Engineering Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Genetic Engineering Drug
12.3 Genetic Engineering Drug Production Process
12.4 Genetic Engineering Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Genetic Engineering Drug Typical Distributors
13.3 Genetic Engineering Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Genetic Engineering Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Genetic Engineering Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 5. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
Table 6. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biotech Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Biotech Pharmaceutical Major Business
Table 9. Biotech Pharmaceutical Genetic Engineering Drug Product and Services
Table 10. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 12. Anhui Anke Biotechnology Major Business
Table 13. Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
Table 14. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. GeneScience Pharmaceuticals Major Business
Table 17. GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
Table 18. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Beijing SL Pharmaceutical Major Business
Table 21. Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
Table 22. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Jiangsu Sihuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Sihuan Bioengineering Major Business
Table 25. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
Table 26. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base and Competitors
Table 28. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 29. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
Table 30. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. 3SBio Basic Information, Manufacturing Base and Competitors
Table 32. 3SBio Major Business
Table 33. 3SBio Genetic Engineering Drug Product and Services
Table 34. 3SBio Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Tonghua Dongbao Pharmaceutical Major Business
Table 37. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
Table 38. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Genetic Engineering Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Genetic Engineering Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Genetic Engineering Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Genetic Engineering Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Genetic Engineering Drug Production Site of Key Manufacturer
Table 44. Genetic Engineering Drug New Entrant and Capacity Expansion Plans
Table 45. Genetic Engineering Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Genetic Engineering Drug Sales by Region (2017-2022) & (K Units)
Table 47. Global Genetic Engineering Drug Sales by Region (2023-2028) & (K Units)
Table 48. Global Genetic Engineering Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Genetic Engineering Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 51. Global Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 52. Global Genetic Engineering Drug Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Genetic Engineering Drug Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Genetic Engineering Drug Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Genetic Engineering Drug Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 57. Global Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 58. Global Genetic Engineering Drug Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Genetic Engineering Drug Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Genetic Engineering Drug Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Genetic Engineering Drug Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)
Table 63. North America Genetic Engineering Drug Sales by Country (2023-2028) & (K Units)
Table 64. North America Genetic Engineering Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Genetic Engineering Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 67. North America Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 68. North America Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 69. North America Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 70. Europe Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)
Table 71. Europe Genetic Engineering Drug Sales by Country (2023-2028) & (K Units)
Table 72. Europe Genetic Engineering Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Genetic Engineering Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 75. Europe Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 76. Europe Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 77. Europe Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Genetic Engineering Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Genetic Engineering Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Genetic Engineering Drug Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Genetic Engineering Drug Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 86. South America Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)
Table 87. South America Genetic Engineering Drug Sales by Country (2023-2028) & (K Units)
Table 88. South America Genetic Engineering Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Genetic Engineering Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 91. South America Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 92. South America Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 93. South America Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Genetic Engineering Drug Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Genetic Engineering Drug Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Genetic Engineering Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Genetic Engineering Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Genetic Engineering Drug Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Genetic Engineering Drug Sales by Application (2023-2028) & (K Units)
Table 102. Genetic Engineering Drug Raw Material
Table 103. Key Manufacturers of Genetic Engineering Drug Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Genetic Engineering Drug Typical Distributors
Table 107. Genetic Engineering Drug Typical Customers
List of Figures
Figure 1. Genetic Engineering Drug Picture
Figure 2. Global Genetic Engineering Drug Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibody
Figure 4. Recombinant Human Erythropoietin
Figure 5. Recombinant Human Interferon
Figure 6. Recombinant Human Growth Hormone
Figure 7. Recombinant Human Insulin
Figure 8. Global Genetic Engineering Drug Revenue Market Share by Application in 2021
Figure 9. Medicine
Figure 10. Research
Figure 11. Industrial
Figure 12. Agriculture
Figure 13. Other
Figure 14. Global Genetic Engineering Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Genetic Engineering Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Genetic Engineering Drug Sales (2017-2028) & (K Units)
Figure 17. Global Genetic Engineering Drug Price (2017-2028) & (USD/Unit)
Figure 18. Global Genetic Engineering Drug Production Capacity (2017-2028) & (K Units)
Figure 19. Global Genetic Engineering Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Genetic Engineering Drug Market Drivers
Figure 21. Genetic Engineering Drug Market Restraints
Figure 22. Genetic Engineering Drug Market Trends
Figure 23. Global Genetic Engineering Drug Sales Market Share by Manufacturer in 2021
Figure 24. Global Genetic Engineering Drug Revenue Market Share by Manufacturer in 2021
Figure 25. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Genetic Engineering Drug Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Genetic Engineering Drug Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Genetic Engineering Drug Sales Market Share by Region (2017-2028)
Figure 29. Global Genetic Engineering Drug Revenue Market Share by Region (2017-2028)
Figure 30. North America Genetic Engineering Drug Revenue (2017-2028) & (USD Million)
Figure 31. Europe Genetic Engineering Drug Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Genetic Engineering Drug Revenue (2017-2028) & (USD Million)
Figure 33. South America Genetic Engineering Drug Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Genetic Engineering Drug Revenue (2017-2028) & (USD Million)
Figure 35. Global Genetic Engineering Drug Sales Market Share by Type (2017-2028)
Figure 36. Global Genetic Engineering Drug Revenue Market Share by Type (2017-2028)
Figure 37. Global Genetic Engineering Drug Price by Type (2017-2028) & (USD/Unit)
Figure 38. Global Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 39. Global Genetic Engineering Drug Revenue Market Share by Application (2017-2028)
Figure 40. Global Genetic Engineering Drug Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Genetic Engineering Drug Sales Market Share by Type (2017-2028)
Figure 42. North America Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 43. North America Genetic Engineering Drug Sales Market Share by Country (2017-2028)
Figure 44. North America Genetic Engineering Drug Revenue Market Share by Country (2017-2028)
Figure 45. United States Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Genetic Engineering Drug Sales Market Share by Type (2017-2028)
Figure 49. Europe Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 50. Europe Genetic Engineering Drug Sales Market Share by Country (2017-2028)
Figure 51. Europe Genetic Engineering Drug Revenue Market Share by Country (2017-2028)
Figure 52. Germany Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Genetic Engineering Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Genetic Engineering Drug Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Genetic Engineering Drug Revenue Market Share by Region (2017-2028)
Figure 61. China Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Genetic Engineering Drug Sales Market Share by Type (2017-2028)
Figure 68. South America Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 69. South America Genetic Engineering Drug Sales Market Share by Country (2017-2028)
Figure 70. South America Genetic Engineering Drug Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Genetic Engineering Drug Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Genetic Engineering Drug Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Genetic Engineering Drug Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Genetic Engineering Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2021
Figure 82. Manufacturing Process Analysis of Genetic Engineering Drug
Figure 83. Genetic Engineering Drug Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs